ווטריינט 200 מג
novartis israel ltd - pazopanib as hydrochloride - טבליות מצופות פילם - pazopanib as hydrochloride 200 mg - pazopanib - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.
ווטריינט 400 מג
novartis israel ltd - pazopanib as hydrochloride - טבליות מצופות פילם - pazopanib as hydrochloride 400 mg - pazopanib - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.
ווטריינט 200 מ"ג
glaxo smith kline (israel) ltd - pazopanib as hydrochloride 200 mg - film coated tablets - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.
ווטריינט 400 מ"ג
glaxo smith kline (israel) ltd - pazopanib as hydrochloride 400 mg - film coated tablets - pazopanib - renal cell carcinoma (rcc)votrient is indicated in adults for the first line treatment of advanced renal cell carcinoma (rcc) and for patients who have received prior cytokine therapy for advanced disease.soft tissue sarcoma (sts)votrient is indicated for the treatment of adult patients with selective subtypes of advanced soft tissue sarcoma (sts) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.
אקסיטיניב טבע 1 מג
teva israel ltd - axitinib - טבליות מצופות פילם - axitinib 1 mg - axitinib
אקסיטיניב טבע 3 מג
teva israel ltd - axitinib - טבליות מצופות פילם - axitinib 3 mg - axitinib
אקסיטיניב טבע 5 מג
teva israel ltd - axitinib - טבליות מצופות פילם - axitinib 5 mg - axitinib
סוניטיניב טבע 12.5 מג
teva israel ltd - sunitinib as base - קפסולות - sunitinib as base 12.5 mg - sunitinib
סוניטיניב טבע 25 מג
teva israel ltd - sunitinib as base - קפסולות - sunitinib as base 25 mg - sunitinib
סוניטיניב טבע 37.5 מג
teva israel ltd - sunitinib as base - קפסולות - sunitinib as base 37.5 mg - sunitinib